Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.
440 F. App'x 924
CourtCourt of Appeals for the Federal Circuit
DecidedDecember 6, 2011
DocketNo. 2011-1203
StatusPublished
This text of 440 F. App'x 924 (Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc., 440 F. App'x 924 (Fed. Cir. 2011).
Opinion
[925]*925ON MOTION
ORDER
Mylan Pharmaceuticals Inc. and Mylan Inc. move to dismiss their appeal.
Upon consideration thereof,
It Is Ordered That:
(1) The motion is granted. The appeal is dismissed.
(2) Each side shall bear its own costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
440 F. App'x 924, Counsel Stack Legal Research, https://law.counselstack.com/opinion/novartis-pharmaceuticals-corp-v-mylan-pharmaceuticals-inc-cafc-2011.